Inductive Bio
Brooklyn, US · Founded 2021 · Delaware corporation · 44 employees on LinkedIn · 10 known investors
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
Founders & leadership
Inductive Bio was founded in 2021 by Josh Haimson, Ben Birnbaum, and Alexander Taylor.
JH
Josh HaimsoninCo-Founder and CEO
BB
Ben BirnbauminPh.D.
AT
Alexander TaylorinPh.D.Medicinal chemist who has led project and chemistry teams from screening through development candidate nomination, now working on Inductive Bio, which builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers.
Board
RG
Investors · 10
AlleyCorpNew York · $1M – $5M
Andreessen HorowitzMenlo Park · $500K – $50M
Coalition OperatorsDover · $500K
Lux CapitalNew York · $100K – $100M
Obvious VenturesSan Francisco · $250K – $6Mvia Vishal Vasishth · led
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
Axial VCreportedSan Francisco · $100K – $5M
Bessemer Venture PartnersreportedRedwood City · $5M – $100M
Characterreported · 2 sourcesMilwaukee · $2M
S32reportedPalo Alto
Funding
SEC filings, press & company announcements$25.1M disclosed across 1 of 2 rounds · 2023–2025
- Undisclosed amountSeedDec 2023Source ↗
▶$25.1MraisedMay 2025 · 10 investors · Other TechnologyRule 506(b)
▶$25.1MraisedMay 2025 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin Edward BirnbaumExecutive Officer, Director
- Joshua Daniel HaimsonExecutive Officer, Director
- Rohan GaneshDirector
- Offering amount
- $25.1M
- Amount sold
- $25.1M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Recursion (NASDAQ: RXRX)25 shared keywordsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
Numerion Labs15 shared keywordsNumerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.
Companies competing with Inductive Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Inductive Bio do?
- Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
- Who founded Inductive Bio?
- Inductive Bio was founded by Josh Haimson, Ben Birnbaum, Alexander Taylor in 2021.
- Who are Inductive Bio's investors?
- Inductive Bio's investors include AlleyCorp, Andreessen Horowitz, Coalition Operators, Lux Capital, Obvious Ventures, Alley Robotics Ventures, Axial VC, Bessemer Venture Partners and 2 more.
- How much funding has Inductive Bio raised?
- Inductive Bio has disclosed $25.1M raised across 1 of its 2 known rounds.
- Where is Inductive Bio headquartered?
- Inductive Bio is headquartered in Brooklyn, US.